Skip to main content
. 2015 Jul 29;10(7):e0133877. doi: 10.1371/journal.pone.0133877

Fig 1. Activity of EB, vancomycin and linezolid against intracellular MRSA USA300 in J774A.1 cells.

Fig 1

MRSA infected J774A.1 cells were treated with EB and control antibiotics (vancomycin and linezolid) for 24 h and the percent bacterial reduction was calculated compared to untreated control groups. The results are given as means ± SD (n = 3). P values of (**, # ≤ 0.05) are considered as significant. EB was compared to controls (**) and to antibiotics (#).